Skip to main content
. 2013 Jun 5;2013(6):CD006335. doi: 10.1002/14651858.CD006335.pub3

Ma 2001.

Methods
  • Randomisation mentioned, but not described in detail

Participants
  • Country: China

  • Primary nephrotic syndrome (urinary protein > 3.5g/24 h; plasma albumin < 30 g/dL; oedema and hypercholesterolaemia)

  • Number: treatment group (10); control group (10)

  • Age range: NS

  • Sex (M/F): NS

  • Exclusions: secondary nephrotic syndrome

Interventions Treatment group
  • Huangqi with Yimucao decoction

    • Dose: twice a day

  • Drugs the control group received


Control group
  • Prednisone

Outcomes
  • Plasma albumin

  • 24 hours urine protein

  • Blood cholesterol

  • oedema

Notes
  • Baseline declining kidney function: NS

  • Remission: NS

  • Pathology: NS

  • Relapse: NS

  • Time to relapse: NS

  • Mean follow‐up: NS

  • Dosage: described in detail

  • Prepare method: NS

  • Source of funding: none